spacer
home > events calendar
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR
   
  
EVENTS FOR 2017
   
 
EVENTS FOR ICT
 
     

8th Clinical Quality Oversight Forum 2017

11-13 October 2017
Sheraton Philadelphia Downtown Hotel, Philadelphia, PA

ExL’s Clinical Quality Oversight Forum continues to live up to its reputation as an elite gathering of senior-level executives. More>>

 
phone +44 (0) 20 7724 3456
web bit.ly/2tTxggs
email Sheraton Philadelphia Downtown Hotel, Philadelphia, PA
 

Outsourcing in Clinical Trials Nordics 2017

10-11 October 2017
Copenhagen, Denmark

Enabling local knowledge-sharing, benchmarking and network-building between Nordic biopharma and device industry peers More>>

 
web www.arena-international.com/octnordics
email Copenhagen, Denmark
 
spacer
Industry Events

BIO-Europe® 2017

6-8 November 2017, Messedamm 26 14055 Berlin Germany

The 23rd annual BIO-Europe® event is the largest biotechnology partnering conference held in Europe. Over 3,800 global decision makers from biotechnology, pharma and finance annually attend BIO-Europe to identify new business opportunities and develop strategic relationships. Business development executives and dealmakers consider BIO-Europe a must-attend event and an effective business strategy enabling them to meet and present to numerous potential partners. BIO-Europe features the industry’s most advanced web-based partnering system enabling delegates from all parts of the biotechnology value chain to quickly identify, engage and enter into strategic relationships that drive their business successfully forward. BIO-Europe's world-class workshops, panels and active exhibition along with thousands of prescheduled one-to-one meetings make this event an unrivaled forum for companies across the biotech value chain to meet and do business.
More info >>

White Papers

Biosimilars In Emerging Markets: Is It A Level Playing Field?

PRA Health Sciences (PRA)

Governments, healthcare payers, and social and health reforms, combined with the increased incidence of conditions such as cancer and diabetes are paving the way for increased uptake of biologic medicines in emerging markets. However, expensive biologic medicines can be prohibitive to many patients, creating a high level of unmet clinical need. At its best, the global expansion of biosimilars can mean a robust and steady supply of existing and new drugs reaching far-flung patient populations, but localized biosimilar drug developments, especially in China and India, combined with a lack of robust pharmacovigilance systems, threaten to derail the industry by putting patient health at risk.
More info >>


News and Press Releases

CPhI Worldwide Pharma Awards finalists unveiled

CPhI Worldwide, organised by UBM, announces the finalists of the 2017 CPhI Pharma Awards. Such was the quality; a record 98 entries have been shortlisted, with the winners due to be announced during this year’s CPhI Worldwide in Frankfurt.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement